Skip to content
Menu

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $70

Benzinga Newsdesk 27 minutes ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $69 to $70.

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $69 to $70.

Read at benzinga.com